| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Pathology and Program in Molecular Biology, University of Colorado Health Sciences Center, Denver, Colorado 80262
Address all correspondence and requests for reprints to: Steven K. Nordeen, Department of Pathology B216, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Denver, Colorado 80262. E-mail: steve.nordeen{at}uchsc.edu.
Glucocorticoids and progestins bind to receptors that share many structural and functional similarities, including virtually identical DNA recognition specificity. Nonetheless, the two hormones mediate very distinct biological functions. For example, progestins are associated with the incidence and progression of breast cancer, whereas glucocorticoids are growth suppressive in mammary cancer cells. To understand the mechanisms that engender biological specificity, it is necessary to identify genes that are differentially regulated by the two receptors. Here we employ Affymetrix oligonucleotide arrays to compare glucocorticoid- and progestin-regulated gene expression in a human breast cancer cell line. This global analysis reveals that the two hormones regulate overlapping but distinct sets of genes, including 31 genes that are differentially regulated. Surprisingly, the set of differentially regulated genes was almost as large as the set of genes regulated by both hormones. Examination of the set of differentially regulated genes suggests mechanisms behind the distinct growth effects of the two hormones in breast cancer. The differential regulation of four genes representing different regulatory patterns was confirmed by RT-PCR and Northern blot analyses. Treatment with cycloheximide or RU486 indicates that the regulation is a primary, receptor-mediated event. Detailed analyses of genes identified in these studies will furnish a mechanistic understanding of differential regulation by glucocorticoids and progestins.
This article has been cited by other articles:
 |
|
 |
|
  B. M. Jacobsen, P. Jambal, S. A. Schittone, and K. B. Horwitz ALU Repeats in Promoters Are Position-Dependent Co-Response Elements (coRE) that Enhance or Repress Transcription by Dimeric and Monomeric Progesterone Receptors Mol. Endocrinol., July 1, 2009; 23(7): 989 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Magklara and C. L. Smith A Composite Intronic Element Directs Dynamic Binding of the Progesterone Receptor and GATA-2 Mol. Endocrinol., January 1, 2009; 23(1): 61 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Subtil-Rodriguez, L. Millan-Arino, I. Quiles, C. Ballare, M. Beato, and A. Jordan Progesterone Induction of the 11{beta}-Hydroxysteroid Dehydrogenase Type 2 Promoter in Breast Cancer Cells Involves Coordinated Recruitment of STAT5A and Progesterone Receptor to a Distal Enhancer and Polymerase Tracking Mol. Cell. Biol., June 1, 2008; 28(11): 3830 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Trotter, H.-Y. Fan, M. L. Ivey, R. E. Kingston, and T. K. Archer The HSA Domain of BRG1 Mediates Critical Interactions Required for Glucocorticoid Receptor-Dependent Transcriptional Activation In Vivo Mol. Cell. Biol., February 15, 2008; 28(4): 1413 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Hebbar and T. K. Archer Chromatin-dependent Cooperativity between Site-specific Transcription Factors in Vivo J. Biol. Chem., March 16, 2007; 282(11): 8284 - 8291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Graham, M. L. Yager, H. D. Hill, K. Byth, G. M. O'Neill, and C. L. Clarke Altered Progesterone Receptor Isoform Expression Remodels Progestin Responsiveness of Breast Cancer Cells Mol. Endocrinol., November 1, 2005; 19(11): 2713 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Wang and S. S. Simons Jr. Corepressor Binding to Progesterone and Glucocorticoid Receptors Involves the Activation Function-1 Domain and Is Inhibited by Molybdate Mol. Endocrinol., June 1, 2005; 19(6): 1483 - 1500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Palmieri, D. O. Halverson, T. Ouatas, C. E. Horak, M. Salerno, J. Johnson, W. D. Figg, M. Hollingshead, S. Hursting, D. Berrigan, et al. Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor-Negative Breast Cancer J Natl Cancer Inst, May 4, 2005; 97(9): 632 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. White, M. M. Yore, D. Deng, and M. J. Spinella Limiting Effects of RIP140 in Estrogen Signaling: POTENTIAL MEDIATION OF ANTI-ESTROGENIC EFFECTS OF RETINOIC ACID J. Biol. Chem., March 4, 2005; 280(9): 7829 - 7835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Trotter and T. K. Archer Reconstitution of Glucocorticoid Receptor-Dependent Transcription In Vivo Mol. Cell. Biol., April 15, 2004; 24(8): 3347 - 3358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. L. Leo, C. Guo, C. T. Woon, S. E. Aw, and V. C. L. Lin Glucocorticoid and Mineralocorticoid Cross-Talk with Progesterone Receptor to Induce Focal Adhesion and Growth Inhibition in Breast Cancer Cells Endocrinology, March 1, 2004; 145(3): 1314 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Cunliffe, M. Ringner, S. Bilke, R. L. Walker, J. M. Cheung, Y. Chen, and P. S. Meltzer The Gene Expression Response of Breast Cancer to Growth Regulators: Patterns and Correlation with Tumor Expression Profiles Cancer Res., November 1, 2003; 63(21): 7158 - 7166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fahnenstich, A. Nandy, K. Milde-Langosch, T. Schneider-Merck, N. Walther, and B. Gellersen Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells Mol. Hum. Reprod., October 1, 2003; 9(10): 611 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. RHEN, S. GRISSOM, C. AFSHARI, and J. A. CIDLOWSKI Dexamethasone blocks the rapid biological effects of 17{beta}-estradiol in the rat uterus without antagonizing its global genomic actions FASEB J, October 1, 2003; 17(13): 1849 - 1870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wan and S. K. Nordeen Overlapping but Distinct Profiles of Gene Expression Elicited by Glucocorticoids and Progestins Recent Prog. Horm. Res., January 1, 2003; 58(1): 199 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Planey, M. T. Abrams, N. M. Robertson, and G. Litwack Role of Apical Caspases and Glucocorticoid-regulated Genes in Glucocorticoid-induced Apoptosis of Pre-B Leukemic Cells Cancer Res., January 1, 2003; 63(1): 172 - 178. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
